Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun:29:S48-S55.
doi: 10.1016/j.rcreu.2021.01.004. Epub 2021 Feb 27.

[Guillain-Barré syndrome as an autoimmune neurological manifestation associated with COVID-19: A review of the literature]

[Article in Spanish]
Yonatan Andrés Naranjo Arango  1 , Juan Pablo García Henao  1 , Abraham Yamit Amin Ariff Farfán Cortés  1 , Daniela Álvarez Correa  1
Affiliations
Review

[Guillain-Barré syndrome as an autoimmune neurological manifestation associated with COVID-19: A review of the literature]

[Article in Spanish]
Yonatan Andrés Naranjo Arango et al. Rev Colomb Reumatol. 2022 Jun.

Abstract
in English, Spanish

The coronavirus disease (COVID-19) caused by SARS-CoV-2 has been a challenge for health services around the world. The pandemic has spread widely, with more than 80 million confirmed cases and more than one million deaths globally. There have been many studies to understand all aspects of the disease. Recently, several cases have been reported of patients with Guillain-Barré syndrome associated with COVID-19 as the main manifestation. As it may be one of the first autoimmune neurological diseases triggered by SARS-CoV-2, it is necessary to obtain more information to fully understand the immunopathogenic mechanisms involved in this association.

La enfermedad por coronavirus (COVID-19) producida por el SARS-CoV-2 ha sido un reto para los servicios de salud en todo el mundo. La pandemia se ha extendido ampliamente con más de 80 millones de casos confirmados y más de un millón de muertes a nivel mundial, por lo que ha estado bajo constante investigación para entender todos los aspectos de la enfermedad. Recientemente se han reportado varios casos de pacientes con síndrome de Guillain-Barré asociado a COVID-19 como manifestación principal, convirtiéndola en la primera enfermedad neurológica autoinmune desencadenada por SARS-CoV-2; sin embargo, es necesario obtener más información para entender completamente los mecanismos inmunopatogénicos implicados en esta asociación.

Keywords: COVID-19; Coronavirus; Guillain-Barré syndrome; Rheumatic diseases.

PubMed Disclaimer

Figures

Figura 1
Figura 1
Flujograma de selección de artículos.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Saldarriaga Rivera L.M., Fernández Ávila D., Bautista Molano W., Jaramillo Arroyave D., Bautista Ramírez A.J., Díaz Maldonado A., et al. Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection Colombian Association of Rheumatology. Reumatol Clin. 2020;16:437–446. doi: 10.1016/j.reumae.2020.06.006. - DOI - PMC - PubMed
    1. Lai C.C., Ko W.C., Lee P.I., Jean S.S., Hsueh P.R. Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020;56:106024. doi: 10.1016/j.ijantimicag.2020.106024. - DOI - PMC - PubMed
    1. Ahmad I., Rathore F.A. Neurological manifestations and complications of COVID-19: A literature review. J Clin Neurosci. 2020;77:8–12. doi: 10.1016/j.jocn.2020.05.017. - DOI - PMC - PubMed
    1. Lvov D.K., Alkhovsky S.V., Kolobukhina L.V., Burtseva E.I. [Etiology of epidemic outbreaks COVID-19 in Wuhan, Hubei province Chinese people republic associated with 2019-ncov (nidovirales, coronaviridae, coronavirinae, betacoronavirus, subgenus sarbecovirus): lessons of SARS-CoV outbreak] Vopr Virusol. 2020;65:6–15. doi: 10.36233/0507-4088-2020-65-1-6-15. - DOI - PubMed
    1. World Health Organization (WHO) Novel coronavirus - China [Internet]. 2020 [consultado 19 May 2020]. Disponible en: https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/